{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:46:35Z","timestamp":1792003595638,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Korea Healthcare technology R&D Project"},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A121861"],"award-info":[{"award-number":["A121861"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ajo.2014.11.035","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T19:45:11Z","timestamp":1418067911000},"page":"519-527.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Long-term Result of Maintenance Treatment With Tacrolimus Ointment in Chronic Ocular Graft-Versus-Host Disease"],"prefix":"10.1016","volume":"159","author":[{"given":"Ji Won","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Chul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-im","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eung Kweon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Yul","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2014.11.035_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0161-6420(83)34604-2","article-title":"Ocular manifestations of graft-vs-host disease","volume":"90","author":"Franklin","year":"1983","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2014.11.035_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.ajo.2014.11.035_bib3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bjo.83.10.1125","article-title":"Dry eye after haematopoietic stem cell transplantation","volume":"83","author":"Ogawa","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2014.11.035_bib4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/bmt.2009.312","article-title":"Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye","volume":"45","author":"Wang","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ajo.2014.11.035_bib5","first-page":"111","article-title":"A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD","volume":"42","author":"Ogawa","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2014.11.035_bib6","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1167\/iovs.02-0699","article-title":"Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease","volume":"44","author":"Ogawa","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2014.11.035_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bmt.1704453","article-title":"Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease","volume":"33","author":"Robinson","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ajo.2014.11.035_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","volume":"24","author":"Joseph","year":"2005","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2014.11.035_bib9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","article-title":"Novel immunosuppressive agent, FK506, in\u00a0vitro effects on the cloned T\u00a0cell activation","volume":"139","author":"Sawada","year":"1987","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.ajo.2014.11.035_bib10","first-page":"2737","article-title":"Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye","volume":"34","author":"Pleyer","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2014.11.035_bib11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajo.2012.12.009","article-title":"Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases","volume":"155","author":"Lee","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2014.11.035_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/11587010-000000000-00000","article-title":"Tacrolimus in the treatment of ocular diseases","volume":"25","author":"Zhai","year":"2011","journal-title":"BioDrugs"},{"issue":"9","key":"10.1016\/j.ajo.2014.11.035_bib13","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archderm.137.9.1202","article-title":"Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients","volume":"137","author":"Choi","year":"2001","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.ajo.2014.11.035_bib14","first-page":"665","article-title":"Topical tacrolimus\u2013a novel treatment alternative for cutaneous chronic graft-versus-host disease","volume":"16","author":"Elad","year":"2003","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.ajo.2014.11.035_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1399-3046.2006.00666.x","article-title":"Oral graft vs. host disease in children\u2013treatment with topical tacrolimus ointment","volume":"11","author":"Albert","year":"2007","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.ajo.2014.11.035_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bmt.2009.249","article-title":"Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD","volume":"45","author":"Tam","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.ajo.2014.11.035_bib17","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ophtha.2007.07.025","article-title":"Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases","volume":"115","author":"Miyazaki","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2014.11.035_bib18","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I)","volume":"3","author":"Ogawa","year":"2013","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ajo.2014.11.035_bib19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2014.11.035_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","volume":"12","author":"Couriel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7 Suppl","key":"10.1016\/j.ajo.2014.11.035_bib21","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00003226-200310001-00004","article-title":"Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation","volume":"22","author":"Ogawa","year":"2003","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2014.11.035_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00003226-200205000-00024","article-title":"Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506)","volume":"21","author":"Ahmad","year":"2002","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2014.11.035_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3341\/kjo.2012.26.4.241","article-title":"Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis","volume":"26","author":"Ryu","year":"2012","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2014.11.035_bib24","first-page":"100","article-title":"Interspecies comparison of the immunosuppressive efficacy and safety of FK 506","volume":"22","author":"Thomson","year":"1990","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.ajo.2014.11.035_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jop.2008.0125","article-title":"Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration","volume":"25","author":"Yuan","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2014.11.035_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/jop.2011.0108","article-title":"Ocular safety and pharmacokinetics study of FK506 suspension eye drops after corneal transplantation","volume":"28","author":"Yuan","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2014.11.035_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","article-title":"A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis","volume":"26","author":"Ohashi","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ajo.2014.11.035_bib28","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1089\/jop.2012.0265","article-title":"Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops","volume":"29","author":"Sanz-Marco","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2014.11.035_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: a review","volume":"58","author":"Shikari","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2014.11.035_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ajo.2014.11.035_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1076\/ocii.6.1.51.8079","article-title":"Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis","volume":"6","author":"Whitcup","year":"1998","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.ajo.2014.11.035_bib32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/ICO.0b013e3181a16472","article-title":"High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen","volume":"28","author":"Dastjerdi","year":"2009","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2014.11.035_bib33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2014.11.035_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705900","article-title":"Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease","volume":"41","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ajo.2014.11.035_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","article-title":"Topical tacrolimus treatment of atopic eyelid disease","volume":"135","author":"Rikkers","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2014.11.035_bib36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/ICO.0b013e318243f69d","article-title":"Tacrolimus ointment 0.03% for treatment of refractory childhood phlyctenular keratoconjunctivitis","volume":"31","author":"Kymionis","year":"2012","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2014.11.035_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.2006.097428","article-title":"Tacrolimus immunosuppression in high-risk corneal grafts","volume":"91","author":"Joseph","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2014.11.035_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00003226-200403000-00013","article-title":"Kaposi varicelliform eruption associated with 0.1% tacrolimus ointment treatment in atopic blepharitis","volume":"23","author":"Miyake-Kashima","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2014.11.035_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2407-6-7","article-title":"The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report","volume":"6","author":"Becker","year":"2006","journal-title":"BMC Cancer"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414007806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414007806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:14:10Z","timestamp":1757596450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939414007806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0002939414007806"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2014.11.035","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Result of Maintenance Treatment With Tacrolimus Ointment in Chronic Ocular Graft-Versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2014.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}